Editor's Picks

Pfizer (NYSE:PFE) faces a $16 to $18 billion loss in revenue from 2025 through 2030 as it loses essential patents on five drugs.The drugs account for 40% of the company's Q3 revenue when its COVID...

Share repurchases might be on increase as firms pivot from a new tax in 2023 Management teams appear to be accelerating stock buybacks PKW ETF offers exposure to value and cyclical stocks while...

CPI reading due in China on Tuesday, in the US on Thursday China reiterates commitment to COVID-zero approach US CPI could give timeline on Fed rate pivot Weak number could signal recession From the...

It is a big week, with the CPI report on Thursday and a bunch of government bond auctions later this week. That means rates will be on the move, and word that the China zero covid policy will remain...

Last week's natural gas close at $6.4 has increased the probabilities of repetition of historical moves in different time frames.The weekly opening levels and follow-up moves on the first trading...

The apparent hawkishness of Fed Chair Powell's comments at the press conference following the FOMC's fourth consecutive rate hike extended the dollar's recovery, which had begun in late...

A low CPI will lower outlook for rate hikes Polls have Republicans in lead; Democratic surprise win will raise fears of more spending Last week, yield curve inverted the most in 40 years Two...

U.S. inflation data, more earnings, midterm elections in focus Occidental Petroleum stock is a buy ahead of explosive earnings Palantir set for losses amid slowing profit, sales growth Stocks on Wall...